Immune Support Peptides
Thymic and immune-modulating peptides studied for T-cell activation and immune function.
Immune peptides modulate the body's immune response at a fundamental level. Thymosin Alpha-1 is produced naturally by the thymus gland and plays a key role in T-cell maturation and activation. It is studied in immune deficiency models, chronic infection studies, and cancer study contexts. These compounds represent an important frontier in immunology research.
Thymosin Alpha-1 (TΞ±1) has been studied in over 70 clinical trials covering viral infections, immunodeficiency, and adjuvant therapy in cancer treatment. It acts by stimulating dendritic cell maturation, enhancing Th1 cytokine production (including interferon-Ξ³ and interleukin-2), and promoting NK cell activity. TΞ±1 is registered as a pharmaceutical drug (Zadaxin) in over 35 countries β giving it one of the most extensive safety and efficacy study records of any peptide in this catalog. Its mechanism is fundamentally thymic: restoring the adaptive immune calibration that declines with age and disease.
Thymosin Alpha-1 is particularly relevant to research into chronic infection models, immune-senescence (age-related immune decline), and cancer immunology. The thymus gland naturally involutes (shrinks) with age, reducing T-cell output and adaptive immune surveillance. TΞ±1 supplementation in preclinical and clinical research has been shown to partially compensate for this decline by directly stimulating T-cell progenitors. Our Thymosin Alpha-1 is available in 5mg and 10mg vials with independent COA documentation, sold strictly for laboratory and educational use.
1 Immune Support Peptides Compound
Thymosin Alpha-1 10mg
Thymic peptide for T-cell activation, immune enhancement, and adaptive immunity.
- T-cell maturation and activation
- Adaptive immune enhancement
- Chronic infection resistance